Profile
IMUX NVO VRTX REGN MRNA SGEN
Company Name Immunic, Inc. Novo Nordisk A/S Vertex Pharmaceuticals Incorporated Regeneron Pharmaceuticals, Inc. Moderna, Inc. Seagen Inc.
Sector Healthcare Healthcare Healthcare Healthcare Healthcare Healthcare
Industry Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology Biotechnology
Market Cap $130.61M $575.53B $127.80B $116.89B $46.80B $43.15B
Employees 0.08K 66.02K 5.40K 13.68K 5.60K 3.26K
CEO Dr. Daniel Vitt Ph.D. Mr. Lars Fruergaard Jorgensen Dr. Reshma Kewalramani FASN, M.D. Dr. Leonard S. Schleifer M.D., Ph.D. Mr. Stephane Bancel Mr. David R. Epstein B.Sc., M.B.A.
Ratings
IMUX NVO VRTX REGN MRNA SGEN
Quant Rating Score 2 3 4 4 1 3
Quant Rating Sell Neutral Buy Buy Strong Sell Neutral
Trading
IMUX NVO VRTX REGN MRNA SGEN
Last Close $1.45 $126.73 $495.26 $1078.63 $122.11 $228.74
High 52 $2.41 $199.54 $495.91 $1100.05 $166.61 $228.9
Low 52 $0.97 $87.78 $340.48 $732.12 $69.51 $191.57
Price vs. 52 Week High -39.83 % -36.49 % -0.13 % -1.95 % -26.71 % -0.07 %
Price vs. 52 Week Low 49.48 % 44.37 % 45.46 % 47.33 % 75.67 % 19.4 %
Total Return
IMUX NVO VRTX REGN MRNA SGEN
1 Month Return 42.16 % -12.29 % 4.81 % 2.64 % 0.77 % 0 %
3 Month Return 18.85 % -0.09 % 24.6 % 22.13 % 13.1 % 0 %
6 Month Return 26.64 % 17.27 % 15.13 % 14.74 % 19.94 % 0 %
9 Month Return 36.79 % 35.54 % 39.4 % 39.15 % 69.81 % 6.59 %
YTD Return -3.33 % 22.5 % 21.72 % 22.81 % 22.79 % 0 %
1 Year Return -28.92 % -19.11 % 41.65 % 44.85 % 3.04 % 19.4 %
3 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
5 Year Return 0 % 0 % 0 % 0 % 0 % 0 %
Dividends
IMUX NVO VRTX REGN MRNA SGEN
Dividend Yield Percentage (TTM) - 0.16 % - - - -
Dividend Paid and Capex Coverage Ration (TTM) -288.44 % 1.1 % 8.49 % 6.2 % -3.65 % -3.35 %
Dividend Per Share (TTM) - 0.2 % - - - -
Payout Ratio (TTM) - 47.03 % - - - -
Growth
IMUX NVO VRTX REGN MRNA SGEN
Asset Growth -57.5 % 30.35 % 25.23 % 13.23 % -28.74 % -1.21 %
Gross Profit Growth -44.16 % 32.32 % 9.25 % 6.49 % -85.12 % 22.93 %
Revenue Growth - 31.26 % 10.17 % 7.76 % -64.94 % 24.65 %
Revenue 3 Year - 90.51 % 59.87 % 55.67 % 2356.27 % 91.84 %
Revenue 5 Year - 124.2 % 218.58 % 110.3 % 1070.62 % 215.48 %
Revenue 10 Year - 66.11 % 608.27 % 549.62 % 6447.35 % 494.04 %
EBIT Growth 16.96 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Net Income Growth 39.33 % 50.71 % 8.96 % -8.87 % -156.37 % 9.51 %
Net Income 3 Yeari Growth Per Share 24.74 % 106.79 % 34.59 % 13.48 % -529.9 % -764.83 %
Net Income 5 Yeari Growth Per Share 94.61 % 133.86 % 70.33 % 74.02 % -160.17 % -276.93 %
Net Income 10 Yeari Growth Per Share 99.91 % 98.61 % 809.6 % 871.12 % -2046.03 % -624.16 %
Operating Income Growth 16.96 % 37.11 % -12.94 % -14.6 % -145 % 10.13 %
Operating Cash Flow Growth (CFG) -8.73 % 38.06 % -14.35 % -8.39 % -162.6 % 9.07 %
Operating 3 Year CFG 45.73 % 118.29 % 9.63 % 76.95 % -253.56 % -148.34 %
Operating 5 Year CFG 96.08 % 163.51 % 174.78 % 125.17 % -100.11 % -195.86 %
Operating 10 Year CFG 99.92 % 150.92 % 6084.35 % 713.56 % -4698.89 % -2622.09 %
EPS Growth 56.49 % 52.28 % 8.33 % -8.54 % -158.15 % 10.81 %
EPS Diluted Growth 56.49 % 52.37 % 8.35 % -9.03 % -161.39 % 10.81 %
Book Value Per Share -81.73 % 29 % 25.58 % 15.03 % -25.28 % -9.83 %
Share Holder 3 Year Equity Growth Per Share -93.56 % 75.22 % 104.06 % 137.56 % 439.94 % 33.92 %
Share Holder 5 Year Equity Growth Per Share -94.44 % 121.9 % 291.14 % 219.1 % 92.24 % 220.81 %
Share Holder 10 Year Equity Growth Per Share -99.98 % 49.62 % 1030.79 % 1286.9 % 1519.81 % 691.19 %
Dividend Per Share Growth - 26.89 % - - - -
Dividend 3 Year Growth Per Share - 64.4 % - - - -
Dividend 5 Year Growth Per Share - 80.03 % - - - -
Dividend 10 Year Growth Per Share - 95.44 % - - - -
Debt Growth -14.65 % 4.74 % 44.1 % 0.06 % 3.58 % -23.28 %
Free Cash Flow Growth -9.05 % 9.17 % -16.47 % -17.11 % -183.5 % 3.67 %
Updated On 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2023 31 Dec 2022
Profitability
IMUX NVO VRTX REGN MRNA SGEN
Gross Profit Margin TTM - 84.65 % 86.86 % 87.16 % 21.77 % 75.4 %
Return on Assets TTM -94.02 % 29.87 % 16.81 % 11.22 % -35.67 % -20.64 %
Return on Equity TTM -170.16 % 91.82 % 23.61 % 15.15 % -41.83 % -28.06 %
Return on Capital Employed TTM -114.1 % 82.5 % 20.67 % 12.53 % -35.81 % -29.5 %
Net Income Per EBT TTM 100 % 79.81 % 84.31 % 95.44 % 124.28 % 101.53 %
EBT Per Ebit TTM 102.16 % 101.7 % 114.62 % 104.74 % 93.44 % 93.47 %
EBIT Per Revenue TTM - 45.03 % 40.85 % 29.46 % -99.69 % -34.37 %
Cash Flow To Debt Ratio TTM -6662.3 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Receivables Turnover TTM - 3.87 5.68 2.51 13.32 3.64
Payables Turnover TTM 0.02 2.88 3.81 2.51 22.04 2.52
Inventory Turnover TTM - 1.12 1.65 0.62 13.67 1.07
Fixed Asset Turnover TTM - 248.64 % 685.31 % 310.02 % 186.78 % 471.71 %
Asset Turnover TTM - 81.71 % 42.57 % 38.12 % 30.81 % 63.3 %
Operating Cash Flow Per Share TTM -0.77 20.95 15.27 43.96 -7.54 -2.87
Free Cash Flow Per Share TTM -0.78 11.28 13.48 36.87 -9.61 -3.73
Cash Per Share TTM 100.01 % 208.61 % 3939.31 % 9758.35 % 2235.6 % 657.5 %
Operating Cash Flow Sales Ratio TTM - 38.24 % 38.74 % 36.17 % -55.91 % -23.48 %
Free Cash Flow Operating Cash Flow Ratio TTM 100.35 % 53.85 % 88.22 % 83.87 % 127.41 % 129.82 %
Cash Flow Coverage Ratios TTM -6662.3 % 346.88 % 546.79 % 238.94 % -232.98 % -475.96 %
Price To Free Cash Flows Ratio TTM -1.73 78.64 36.73 29.41 -12.74 -61.54
Price To Operating Cash Flows Ratio TTM -1.87 41.59 32.42 24.54 -16.19 -79.67
Price Cash Flow Ratio TTM -1.87 41.59 32.42 24.54 -16.19 -79.67
Income Statement (TTM)
IMUX NVO VRTX REGN MRNA SGEN
Revenue $0B $232.26B $9.84B $13.12B $6.75B $1.96B
Gross Profit $-0B $196.5B $8.58B $11.3B $2.06B $1.55B
Gross Profit Ratio 0% 84.6% 87.17% 86.16% 30.52% 79.1%
EBITDA $-0.1B $112.94B $3.93B $5.13B $-3.21B $-0.62B
Net Income $-0.09B $83.68B $3.62B $3.95B $-4.71B $-0.61B
EPS Diluted -2.11 18.62 13.89 34.77 -12.34 -3.3
Balance Sheet (MRQ)
IMUX NVO VRTX REGN MRNA SGEN
Long Term Debt $0B $20.53B $0.72B $2.7B $1.22B $0.04B
Total Liabilities $0.03B $207.93B $5.15B $7.11B $4.57B $0.87B
Total Equity $0.03B $106.56B $17.58B $25.97B $13.85B $2.8B
Total Investments $0B $17.5B $3.45B $13.51B $4.68B $1.42B
Total Debt $0B $27.01B $0.81B $2.7B $1.24B $0.04B
Total Assets $0.05B $314.49B $22.73B $33.08B $18.43B $3.67B
Cash Flow Statement (TTM)
IMUX NVO VRTX REGN MRNA SGEN
Net Income $-0.09B $83.68B $3.62B $3.95B $-4.71B $-0.61B
Inventory $0B $-7.42B $-0.32B $-0.27B $0.75B $-0.23B
Dividends Paid $0B $-31.77B $0B $0B $0B $0B
Operating Cash Flow $-0.07B $108.91B $3.54B $4.59B $-3.12B $-0.45B
Capital Expenditure $-0B $-38.9B $-0.26B $-0.93B $-0.71B $-0.08B
Related Stocks
Ticker Name Price
AADI Aadi Bioscience, Inc. 1.58
ABCL AbCellera Biologics Inc. 3.26
ABCM Abcam plc 23.99
ABEO Abeona Therapeutics Inc. 5.1
ABIO ARCA biopharma, Inc. 3.14
ABOS Acumen Pharmaceuticals, Inc. 3.48
ABSI Absci Corporation 4.48
ABUS Arbutus Biopharma Corporation 3.9
ABVC ABVC BioPharma, Inc. 0.7489
ABVX Abivax SA American Depositary Shares 11.86
ACAD ACADIA Pharmaceuticals Inc. 19.14
ACER Acer Therapeutics Inc. 0.9
ACET Adicet Bio, Inc. 1.59
ACGN Aceragen, Inc. 0.3849
ACHL Achilles Therapeutics plc 0.8288
ACHV Achieve Life Sciences, Inc. 4.925
ACIU AC Immune SA 3.91
ACLX Arcellx, Inc. 64.41
ACRV Acrivon Therapeutics, Inc. Common Stock 8.86
ACST Acasti Pharma Inc. 2.76
ETFs With Exposure to IMUX
Ticker ETF Name Weight Percentage Price
VTI Vanguard Total Stock Market Index Fund 0 269.69
IBB iShares Biotechnology ETF 0 148.26
ITOT iShares Core S&P Total U.S. Stock Market ETF 0.00004 119.77
BIB ProShares Ultra Nasdaq Biotechnology 0 68.41
VXF Vanguard Extended Market Index Fund 0 178.79
IWC iShares Micro-Cap ETF 0.03159 129.27
VITNX Vanguard Institutional Total Stock Market Index Fund Institutional Shares 0 93.5
VITPX Vanguard Institutional Total Stock Market Index Fund Institutional Plus Shares 0 93.48
VBAIX Vanguard Balanced Index Fund Institutional Shares 0 47.88
VBIAX Vanguard Balanced Index Fund Admiral Shares 0 47.88
VBINX Vanguard Balanced Index Fund Investor Shares 0 47.88
IBBQ Invesco Nasdaq Biotechnology ETF 0 24.48
DFAS Dimensional U.S. Small Cap ETF 0.00069355 65.05
DFAC Dimensional U.S. Core Equity 2 ETF 0.0000754 33.02
VTSAX Vanguard Total Stock Market Index Fund 0 131.27
BTEC.L iShares Nasdaq US Biotechnology UCITS ETF USD (Acc) 0.01 7.1
VIEIX Vanguard Extended Market Index Fund Institutional Shares 0 135.6
VITSX Vanguard Total Stock Market Index Fund 0 131.29
SWTSX Schwab Total Stock Market Index Fd Select Shs a Series of Schwab Capit 0.000132752 92.7
VEXAX Vanguard Extended Market Index Fd Admiral Shs 0 135.6
JKK iShares Morningstar Small-Cap Growth ETF 0 307.42
JKJ iShares Morningstar Small-Cap ETF 0 231.193
AVSC Avantis U.S. Small Cap Equity ETF 0 56.13
JKL iShares Morningstar Small-Cap Value ETF 0.01 172.726
VEMPX Vanguard Extended Market Index InstlPlus 0 334.63
VSMPX Vanguard Total Stock Mkt Idx Instl Pls 0 246.27
Unlock